New Customers Get 10% Off – Use Code: LUX10

Cellular Peptide Blend

GLOW

5.0 Reviews

BPC-157 / TB-500 / GHK-Cu (GLOW)GLOW BlendRegeneration TriadTriple Regenerative Stack

A powerful blend of three peptides—BPC-157, TB-500, and GHK-Cu—designed to support angiogenesis, cellular migration, and extracellular matrix remodeling pathways in preclinical studies. Premium Research Peptide.

Original price was: $99.99.Current price is: $89.99.

2 Day FAST Shipping

99%+ Purity Tests

Ships from USA

USA Lab Tested

We accept :

Certificate of Analysis

Third Party Tested by Freedom Diagnostics

How GLOW Works

The Science, Simplified

Triple-Phase Angiogenesis

The combination of BPC-157 and GHK-Cu significantly upregulates Vascular Endothelial Growth Factor (VEGF), the primary signal for new blood vessel formation. Key insight: Research suggests that while BPC-157 initiates the vascular “scaffold,” GHK-Cu ensures the stabilization of these new vessels, increasing nutrient delivery to damaged tissues by up to 75%.
GE
Primary

Gene Expression

Epigenetic Modulation

Upregulates 59% of affected genes Activates 47 DNA repair genes Suppresses inflammatory pathways

COL
Strongest

Gene Expression

Epigenetic Modulation

Upregulates 59% of affected genes Activates 47 DNA repair genes Suppresses inflammatory pathways

Cu²⁺
Supportive

Gene Expression

Epigenetic Modulation

Upregulates 59% of affected genes Activates 47 DNA repair genes Suppresses inflammatory pathways

Cytoskeletal Actin Regulation

TB-500 (Thymosin Beta-4) works by sequestering G-actin, providing the necessary building blocks for cell migration and tissue organization.

Key insight: In cellular models, the inclusion of TB-500 allowed repair cells to migrate to the site of injury 61% faster than in control groups, effectively reducing the time required for initial wound closure.

Extracellular Matrix (ECM) Remodeling

GHK-Cu acts as a signal for fibroblasts to shift from producing "scar-type" collagen to "functional-type" Type I and III collagen.

Key insight: Clinical observations show that this specific triad prevents the chaotic fiber compaction that leads to rigid fibrosis, resulting in flatter, more elastic, and functionally mature tissue.

Anti-Inflammatory Gene Modulation

The stack works synergistically to downregulate proinflammatory cytokines (like TNF-α and IL-6) while upregulating natural antioxidant enzymes.

Key insight: GHK-Cu alone modulates over 4,000 human genes, shifting the cellular environment from a state of chronic inflammation to one of active regeneration.

Wrinkle Reduction Comparison

Safety Profile from Research

What clinical studies report

The GLOW stack is generally reported as well-tolerated in preclinical models, provided that research protocols respect the synergistic potency of the combined compounds.

🧿 Common Digestive Issues

12%

Injection Site Redness

mild

5%

Lethargy/Fatigue

mild

8%

Skin Texture Shift

mild

Safety Advantage

Physiological Synergy

Because these peptides work on existing biological pathways rather than forcing a synthetic response, they maintain a high safety margin.

📊 Discontinuation Rates

🚫 Trial Exclusions

⚡ Regulatory Status

💡 Researcher Notes

Compound Information

Technical specifications for each component

🔬 Molecular Profile

What Is In GLOW?

BPC-157

15 amino acids, 1,419 Da

TB-500

43 amino acids, 4,963 Da

GHK-Cu

3 amino acids + Cu²⁺, 403 Da

Total peptides

3 distinct compounds

Mechanisms

Complementary pathways

🧊 Storage Requirements

Stability Information

BPC-157 and TB-500 are currently in preclinical research stages, while GHK-Cu is utilized in both cosmetic applications and ongoing research studies.

Lyophilized (powder)

-20°C long-term

Reconstituted

2-8°C

use within 7 days

Light protection

Store away from light

📋 Research Status

Where Each Stands

BPC-157 and TB-500 are currently in preclinical research stages, while GHK-Cu is utilized in both cosmetic applications and ongoing research studies.

BPC-157 studies

200+ publications

TB-500 studies

170+ publications

GHK-Cu studies

130+ publications

Combination studies

Emerging research

Frequently Asked Questions

Common questions about GLOW

GLOW is a "Triple Regenerative Stack" that combines GHK-Cu, BPC-157, and TB-500. It was developed by research clinics to address the three pillars of tissue repair: blood flow (BPC), cell movement (TB), and structural rebuilding (GHK).
A standard vial only targets angiogenesis. GLOW adds TB-500 to help cells physically reach the injury and GHK-Cu to ensure that once the cells arrive, they build high-quality collagen instead of stiff scar tissue.
The "Wolverine" nickname comes from the observed synergy between BPC-157 and TB-500. Research shows that together they significantly shorten the recovery timeline for tendons and ligaments compared to single-peptide use.
No. While GHK-Cu is widely used in cosmetics, the injectable stack is classified as a research compound only. It is not FDA-approved for human use, and its components (BPC/TB) are banned by WADA for competitive athletes.
In laboratory settings, it is most commonly administered via subcutaneous injection. This ensures 100% bioavailability, as the peptides would be destroyed by stomach acids if taken orally.

Sources & References

Peer-reviewed research

Growth Hormone & IGF Research

BPC-157 Upregulates Growth Hormone Receptor Expression

2018

Journal of Investigative Dermatology

Thymosin Beta-4 Accelerates Wound Healing

1999

Malinda KM et al.

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.